Natarajan Sethuraman
President, Research & Develop. · 3 filings · Latest: Sep 2, 2026
Entrada Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TRDA | Natarajan Sethuraman | President, Research & Develop. | May 4, 2026 | Sale | $15.39 | 25,907 | $398.8K | 216,317 | |
TRDA | NATARAJAN SETHURAMAN | — | May 4, 2026 | Proposed Sale | $14.50 | 25,907 | $375.7K | — | |
TRDA | NATARAJAN SETHURAMAN | — | Nov 11, 2024 | Proposed Sale | $19.82 | 18,762 | $371.9K | — | |
TRDA | NATARAJAN SETHURAMAN | — | Oct 16, 2024 | Proposed Sale | $17.53 | 20,057 | $351.6K | — |